Up-regulation of BLT2 is critical for the survival of bladder cancer cells

Ji Min Seo, Kyung Jin Cho, Eun Young Kim, Man Ho Choi, Bong Chul Chung, Jae-Hong Kim

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The incidence rates of urinary bladder cancer continue to rise yearly, and thus new therapeutic approaches and early diagnostic markers for bladder cancer are urgently needed. Thus, identifying the key mediators and molecular mechanisms responsible for the survival of bladder cancer has valuable implications for the development of therapy. In this study, the role of BLT2, a receptor for leukotriene B 4 (LTB 4) and 12(S)-hydroxyei-cosatetraenoic acid (HETE), in the survival of bladder cancer 253J-BV cells was investigated. We found that the expression of BLT2 is highly elevated in bladder cancer cells. Also, we observed that blockade of BLT2 with an antagonist or BLT2 siRNA resulted in cell cycle arrest and apoptotic cell death, suggesting a role of BLT2 in the survival of human bladder cancer 253J-BV cells. Further experiments aimed at elucidating the mechanism by which BLT2 mediates survival revealed that enhanced level of reactive oxygen species (ROS) are generated via a BLT2-dependent up-regulation of NADPH oxidase members NOX1 and NOX4. Additionally, we observed that inhibition of ROS generation by either NOX1/4 siRNAs or treatment with an ROS-scavenging agent results in apoptotic cell death in 253J-BV bladder cancer cells. These results demonstrated that a 'BLT2-NOX1/4-ROS' cascade plays a role in the survival of this aggressive bladder cancer cells, thus pointing to BLT2 as a potential target for anti-bladder cancer therapy.

Original languageEnglish
Pages (from-to)129-137
Number of pages9
JournalExperimental and Molecular Medicine
Volume43
Issue number3
DOIs
Publication statusPublished - 2011 Mar 1

Fingerprint

Urinary Bladder Neoplasms
Reactive Oxygen Species
Up-Regulation
Cells
Survival
Cell death
Hydroxyeicosatetraenoic Acids
Leukotriene B4
NADPH Oxidase
Scavenging
Small Interfering RNA
Cell Death
Acids
Cell Cycle Checkpoints
Experiments
Therapeutics
Incidence

Keywords

  • Biological markers
  • Cell survival
  • Human
  • LTB4R2 protein
  • NADPH Oxidase
  • Reactive oxygen species
  • Urinary bladder neoplasms

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Molecular Medicine
  • Clinical Biochemistry

Cite this

Up-regulation of BLT2 is critical for the survival of bladder cancer cells. / Seo, Ji Min; Cho, Kyung Jin; Kim, Eun Young; Choi, Man Ho; Chung, Bong Chul; Kim, Jae-Hong.

In: Experimental and Molecular Medicine, Vol. 43, No. 3, 01.03.2011, p. 129-137.

Research output: Contribution to journalArticle

Seo, Ji Min ; Cho, Kyung Jin ; Kim, Eun Young ; Choi, Man Ho ; Chung, Bong Chul ; Kim, Jae-Hong. / Up-regulation of BLT2 is critical for the survival of bladder cancer cells. In: Experimental and Molecular Medicine. 2011 ; Vol. 43, No. 3. pp. 129-137.
@article{7d4673dc330f4684ba806bdb0d4300a7,
title = "Up-regulation of BLT2 is critical for the survival of bladder cancer cells",
abstract = "The incidence rates of urinary bladder cancer continue to rise yearly, and thus new therapeutic approaches and early diagnostic markers for bladder cancer are urgently needed. Thus, identifying the key mediators and molecular mechanisms responsible for the survival of bladder cancer has valuable implications for the development of therapy. In this study, the role of BLT2, a receptor for leukotriene B 4 (LTB 4) and 12(S)-hydroxyei-cosatetraenoic acid (HETE), in the survival of bladder cancer 253J-BV cells was investigated. We found that the expression of BLT2 is highly elevated in bladder cancer cells. Also, we observed that blockade of BLT2 with an antagonist or BLT2 siRNA resulted in cell cycle arrest and apoptotic cell death, suggesting a role of BLT2 in the survival of human bladder cancer 253J-BV cells. Further experiments aimed at elucidating the mechanism by which BLT2 mediates survival revealed that enhanced level of reactive oxygen species (ROS) are generated via a BLT2-dependent up-regulation of NADPH oxidase members NOX1 and NOX4. Additionally, we observed that inhibition of ROS generation by either NOX1/4 siRNAs or treatment with an ROS-scavenging agent results in apoptotic cell death in 253J-BV bladder cancer cells. These results demonstrated that a 'BLT2-NOX1/4-ROS' cascade plays a role in the survival of this aggressive bladder cancer cells, thus pointing to BLT2 as a potential target for anti-bladder cancer therapy.",
keywords = "Biological markers, Cell survival, Human, LTB4R2 protein, NADPH Oxidase, Reactive oxygen species, Urinary bladder neoplasms",
author = "Seo, {Ji Min} and Cho, {Kyung Jin} and Kim, {Eun Young} and Choi, {Man Ho} and Chung, {Bong Chul} and Jae-Hong Kim",
year = "2011",
month = "3",
day = "1",
doi = "10.3858/emm.2011.43.3.014",
language = "English",
volume = "43",
pages = "129--137",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "3",

}

TY - JOUR

T1 - Up-regulation of BLT2 is critical for the survival of bladder cancer cells

AU - Seo, Ji Min

AU - Cho, Kyung Jin

AU - Kim, Eun Young

AU - Choi, Man Ho

AU - Chung, Bong Chul

AU - Kim, Jae-Hong

PY - 2011/3/1

Y1 - 2011/3/1

N2 - The incidence rates of urinary bladder cancer continue to rise yearly, and thus new therapeutic approaches and early diagnostic markers for bladder cancer are urgently needed. Thus, identifying the key mediators and molecular mechanisms responsible for the survival of bladder cancer has valuable implications for the development of therapy. In this study, the role of BLT2, a receptor for leukotriene B 4 (LTB 4) and 12(S)-hydroxyei-cosatetraenoic acid (HETE), in the survival of bladder cancer 253J-BV cells was investigated. We found that the expression of BLT2 is highly elevated in bladder cancer cells. Also, we observed that blockade of BLT2 with an antagonist or BLT2 siRNA resulted in cell cycle arrest and apoptotic cell death, suggesting a role of BLT2 in the survival of human bladder cancer 253J-BV cells. Further experiments aimed at elucidating the mechanism by which BLT2 mediates survival revealed that enhanced level of reactive oxygen species (ROS) are generated via a BLT2-dependent up-regulation of NADPH oxidase members NOX1 and NOX4. Additionally, we observed that inhibition of ROS generation by either NOX1/4 siRNAs or treatment with an ROS-scavenging agent results in apoptotic cell death in 253J-BV bladder cancer cells. These results demonstrated that a 'BLT2-NOX1/4-ROS' cascade plays a role in the survival of this aggressive bladder cancer cells, thus pointing to BLT2 as a potential target for anti-bladder cancer therapy.

AB - The incidence rates of urinary bladder cancer continue to rise yearly, and thus new therapeutic approaches and early diagnostic markers for bladder cancer are urgently needed. Thus, identifying the key mediators and molecular mechanisms responsible for the survival of bladder cancer has valuable implications for the development of therapy. In this study, the role of BLT2, a receptor for leukotriene B 4 (LTB 4) and 12(S)-hydroxyei-cosatetraenoic acid (HETE), in the survival of bladder cancer 253J-BV cells was investigated. We found that the expression of BLT2 is highly elevated in bladder cancer cells. Also, we observed that blockade of BLT2 with an antagonist or BLT2 siRNA resulted in cell cycle arrest and apoptotic cell death, suggesting a role of BLT2 in the survival of human bladder cancer 253J-BV cells. Further experiments aimed at elucidating the mechanism by which BLT2 mediates survival revealed that enhanced level of reactive oxygen species (ROS) are generated via a BLT2-dependent up-regulation of NADPH oxidase members NOX1 and NOX4. Additionally, we observed that inhibition of ROS generation by either NOX1/4 siRNAs or treatment with an ROS-scavenging agent results in apoptotic cell death in 253J-BV bladder cancer cells. These results demonstrated that a 'BLT2-NOX1/4-ROS' cascade plays a role in the survival of this aggressive bladder cancer cells, thus pointing to BLT2 as a potential target for anti-bladder cancer therapy.

KW - Biological markers

KW - Cell survival

KW - Human

KW - LTB4R2 protein

KW - NADPH Oxidase

KW - Reactive oxygen species

KW - Urinary bladder neoplasms

UR - http://www.scopus.com/inward/record.url?scp=79953273234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953273234&partnerID=8YFLogxK

U2 - 10.3858/emm.2011.43.3.014

DO - 10.3858/emm.2011.43.3.014

M3 - Article

VL - 43

SP - 129

EP - 137

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 3

ER -